[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JP2006335651A5 - - Google Patents

Download PDF

Info

Publication number
JP2006335651A5
JP2006335651A5 JP2005158818A JP2005158818A JP2006335651A5 JP 2006335651 A5 JP2006335651 A5 JP 2006335651A5 JP 2005158818 A JP2005158818 A JP 2005158818A JP 2005158818 A JP2005158818 A JP 2005158818A JP 2006335651 A5 JP2006335651 A5 JP 2006335651A5
Authority
JP
Japan
Prior art keywords
poe
fatty acid
acid esters
sorbitan
castor oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005158818A
Other languages
Japanese (ja)
Other versions
JP2006335651A (en
JP4931369B2 (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2005158818A priority Critical patent/JP4931369B2/en
Priority claimed from JP2005158818A external-priority patent/JP4931369B2/en
Publication of JP2006335651A publication Critical patent/JP2006335651A/en
Publication of JP2006335651A5 publication Critical patent/JP2006335651A5/ja
Application granted granted Critical
Publication of JP4931369B2 publication Critical patent/JP4931369B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

界面活性剤は、アニオン界面活性剤、カチオン界面活性剤、両性界面活性剤、非イオン界面活性剤のいずれでもよい。
アニオン界面活性剤の例には、脂肪酸セッケン(ラウリン酸ナトリウム、パルミチン酸ナトリウム等)、ラウリル硫酸カリウム、アルキル硫酸トリエタノールアミンエーテル等が含まれる。
カチオン界面活性剤の例には、塩化ステアリルトリメチルアンモニウム、塩化ベンザルコニウム、ラウリルアミンオキサイド等が含まれる。
両性界面活性剤の例には、イミダゾリン系両性界面活性剤(2−ココイル−2−イミダゾリニウムヒドロキサイド−1−カルボキシエチロキシ2ナトリウム塩等)、ベタイン系界面活性剤(アルキルベタイン、アミドベタイン、スルホベタイン等)、アシルメチルタウリン等が含まれる。
非イオン界面活性剤の例には、イソオクタン酸セチル、ミリスチン酸イソプロピル、イソステアリン酸ヘキシルデシル、アジピン酸ジイソプロピル、セバチン酸ジ−2−エチルヘキシル、乳酸セチル、リンゴ酸ジイソステアリル、ジ−2−エチルヘキサン酸エチレングリコール、ジカプリン酸ネオペンチルグリコール、ジ−2−ヘプチルウンデカン酸グリセリン、トリ−2−エチルヘキサン酸グリセリン、トリ−2−エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ−2−エチルヘキサン酸ペンタンエリトリット等の脂肪酸エステル類、ソルビタン脂肪酸エステル類(ソルビタンモノステアレート、セスキオレイン酸ソルビタン等)、グリセリン脂肪酸類(モノステアリン酸グリセリン等)、プロピレングリコール脂肪酸エステル類(モノステアリン酸プロピレングリコール等)、硬化ヒマシ油誘導体、グリセリンアルキルエーテル、ポリオキシエチレン(POE)ソルビタン脂肪酸エステル類(POEソルビタンモノオレエート、モノステアリン酸ポリオキエチレンソルビタン等)、POEソルビット脂肪酸エステル類(POE−ソルビットモノラウレート等)、POEグリセリン脂肪酸エステル類(POE−グリセリンモノイソステアレート等)、POE脂肪酸エステル類(ポリエチレングリコールモノオレート、POEジステアレート等)、POEアルキルエーテル類(POE2−オクチルドデシルエーテル等)、POEアルキルフェニルエーテル類(POEノニルフェニルエーテル等)、プルロニック型類、POE・POPアルキルエーテル類(POE・POP2−デシルテトラデシルエーテル等)、テトロニック類、POEヒマシ油・硬化ヒマシ油誘導体(POEヒマシ油、POE硬化ヒマシ油等)、ショ糖脂肪酸エステル、アルキルグルコシド等が含まれる。
The surfactant may be any of an anionic surfactant, a cationic surfactant, an amphoteric surfactant, and a nonionic surfactant.
Examples of the anionic surfactant include fatty acid soap (sodium laurate, sodium palmitate, etc.), potassium lauryl sulfate, alkylethanol triethanolamine ether and the like.
Examples of the cationic surfactant include stearyltrimethylammonium chloride, benzalkonium chloride, laurylamine oxide and the like.
Examples of amphoteric surfactants include imidazoline-based amphoteric surfactants (2-cocoyl-2-imidazolinium hydroxide-1-carboxyethyloxy disodium salt, etc.), betaine surfactants (alkyl betaines, amide betaines). , Sulfobetaine, etc.), acylmethyl taurine and the like.
Examples of nonionic surfactants include cetyl isooctanoate, isopropyl myristate, hexyldecyl isostearate, diisopropyl adipate, di-2-ethylhexyl sebacate, cetyl lactate, diisostearyl malate, di-2-ethylhexane Acid ethylene glycol, dicaprate neopentyl glycol, glycerin di-2-heptylundecanoate, glycerol tri-2-ethylhexanoate, trimethylolpropane tri-2-ethylhexanoate, trimethylolpropane triisostearate, tetra-2- Fatty acid esters such as ethylhexanoic acid pentane erythritol, sorbitan fatty acid esters (such as sorbitan monostearate, sorbitan sesquioleate), glycerin fatty acids (such as glyceryl monostearate) Propylene glycol fatty acid esters (propylene glycol monostearate, etc.), hardened castor oil derivatives, glycerin alkyl ethers, polyoxyethylene (POE) sorbitan fatty acid esters (POE sorbitan monooleate, Porioki monostearate shea sorbitan, etc.), POE sorbite fatty acid esters (such as POE-sorbite monolaurate), POE glycerin fatty acid esters (such as POE-glycerin monoisostearate), POE fatty acid esters (polyethylene glycol monooleate, POE distearate, etc.), POE alkyl ethers (POE2-octyldodecyl ether, etc.), POE alkylphenyl ethers (POE nonylphenyl ether, etc.), Pluronic types, POE • P Includes P alkyl ethers (POE / POP2-decyltetradecyl ether, etc.), Tetronics, POE castor oil / hardened castor oil derivatives (POE castor oil, POE hardened castor oil, etc.), sucrose fatty acid ester, alkyl glucoside, etc. It is.

JP2005158818A 2005-05-31 2005-05-31 Liposomes and therapeutic compositions containing the same Expired - Fee Related JP4931369B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005158818A JP4931369B2 (en) 2005-05-31 2005-05-31 Liposomes and therapeutic compositions containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005158818A JP4931369B2 (en) 2005-05-31 2005-05-31 Liposomes and therapeutic compositions containing the same

Publications (3)

Publication Number Publication Date
JP2006335651A JP2006335651A (en) 2006-12-14
JP2006335651A5 true JP2006335651A5 (en) 2008-06-26
JP4931369B2 JP4931369B2 (en) 2012-05-16

Family

ID=37556509

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005158818A Expired - Fee Related JP4931369B2 (en) 2005-05-31 2005-05-31 Liposomes and therapeutic compositions containing the same

Country Status (1)

Country Link
JP (1) JP4931369B2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5657191B2 (en) * 2007-06-19 2015-01-21 ポーラ化成工業株式会社 Vesicle and topical skin preparation containing the same
SG184072A1 (en) 2010-04-01 2012-10-30 Pharmanest Ab Bioadhesive compositions of local anaesthetics
WO2012133817A1 (en) 2011-03-31 2012-10-04 花王株式会社 Vesicle composition
CN103533936B (en) * 2011-05-17 2016-01-13 三菱瓦斯化学株式会社 Containing pyrro-quinoline quinone (PQQ) and sugared liposome
KR101355216B1 (en) 2012-11-19 2014-01-28 홍소영 A facial mask sheet comprising a composition comprising liposomes for accelerating percutaneous absorptionn
JP6368254B2 (en) * 2015-01-28 2018-08-01 花王株式会社 Comprehensive analysis method for lipids

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09110722A (en) * 1995-10-20 1997-04-28 Toray Ind Inc Immunoliposome for transducing tumorous cell of antitumor active substance and its preparation
GR1003359B (en) * 1998-12-24 2000-04-10 �.�. ����������� �.�.�.�. Liposomic niflumic acid-new transdermal anti-inflammatory medicine
JP5107573B2 (en) * 2003-04-25 2012-12-26 ザ ペン ステイト リサーチ ファウンデーション Systemic delivery methods and systems for growth-inhibiting lipid-derived bioactive compounds
AU2005303389A1 (en) * 2004-11-15 2006-05-18 Yissum Research Development Company Of The Hebrew University Of Jerusalem Combination therapy associating preferably a ceramide with a cytotoxic drug

Similar Documents

Publication Publication Date Title
CN1140257C (en) Stable liquid composition comprising high levels of emollients
JP2006335651A5 (en)
JP5166260B2 (en) External preparation for skin containing triterpenic acid
EP1466586A4 (en) Water-in-oil emulsion preparation for external use on skin
RU2015137155A (en) Oral Care Compositions Containing Particles of Polyorganosilsesesquioxane
EP1746141B1 (en) Thickened cleansing compositions
NZ598839A (en) Stabilized liquid and lyophilized adamts13 formulations
Fabbrocini et al. Cosmeceuticals based on Rhealba® Oat plantlet extract for the treatment of acne vulgaris
NZ592647A (en) Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester
CN1341012A (en) Cleaning compositions
TW201129396A (en) Topical formulation
JP2016511236A (en) Skin whitening method using canola extract
AU2019261770A1 (en) Novel formulations
JP2013216640A5 (en)
US8563535B2 (en) Combination composition comprising benzoyl peroxide and adapalene
BRPI0815110A8 (en) delivery systems for solubilizing water-insoluble pharmaceutically active ingredients
DE50004002D1 (en) Dithiocarbamate LIQUID FORMULATIONS
JP6009136B2 (en) Warm foam cosmetics
CA2878633C (en) Use of zinc coceth sulfate as an antibacterial agent against propionibacterium acnes
MXPA01013460A (en) Topical formulations comprising skin penetration agents and the use thereof.
AU2013345094B2 (en) Oral care compositions
KR20190072013A (en) A cosmetic composition having excellent skin cooling with skin moisturizing effect
JP2009256255A5 (en)
JP2006022000A (en) Oil-cleansing cosmetic
JP2003063959A (en) Aging-preventing agent